1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Neuroproteínas-ictus

Neuroproteínas-ictus

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Purroy F, Vena A, Forné C, de Arce AM, Dávalos A, Fuentes B, Arenillas JF, Krupinski J, Gómez-Choco M, Palomeras E, Martí-Fábregas J, Castillo J, Ustrell X, Tejada J, Masjuan J, Garcés M, Benabdelhak I, Serena J.

    Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients.

    CEREBROVASCULAR DISEASES . 47(3-4): 1-14. Nº de citas: 20

    [doi:10.1159/000500205]

  • Masjuan J, Salido L, DeFelipe A, Hernández-Antolín R, Fernández-Golfín C, Cruz-Culebras A, Matute C, Vera R, Pérez-Torre P, Zamorano JL.

    Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.

    EUROPEAN JOURNAL OF NEUROLOGY . 26(5): 816-820. Nº de citas: 10

    [doi:10.1111/ene.13894]

  • Crespo Araico LA, Vera Lechuga R, Cruz-Culebras A, Matute Lozano C, de Felipe Mimbrera A, Agüero Rabes P, Viedma Guiard E, Estévez Fraga C, Masjuan Vallejo J.

    Reperfusion therapy in patients with acute ischaemic stroke caused by cervical artery dissection.

    NEUROLOGIA . 34(3): 153-158. Nº de citas: 3

    [doi:10.1016/j.nrl.2016.11.005]

  • Chioua M, Martínez-Alonso E, Gonzalo-Gobernado R, Ayuso MI, Escobar-Peso A, Infantes L, Hadjipavlou-Litina D, Montoya JJ, Montaner J, Alcázar A, Marco-Contelles J.

    New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.

    JOURNAL OF MEDICINAL CHEMISTRY . 62(4): 2184-2201. Nº de citas: 21

    [doi:10.1021/acs.jmedchem.8b01987]

  • Zapata-Wainberg G, Masjuan J, Quintas S, Ximénez-Carrillo Á, García Pastor A, Martínez Zabaleta M, Cardona P, Freijo Guerrero MM, Llull L, Benavente Fernández L, Castellanos Rodrigo M, Egido J, Serena J, Vivancos J, researchers in the ANITA-FA study.

    The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.

    EUROPEAN JOURNAL OF NEUROLOGY . 26(2): 230-237. Nº de citas: 7

    [doi:10.1111/ene.13792]

  • Regidor I, Santos-García D, Catalán MIJ, Puente V, Valldeoriola F, Grandas F, Mir P, Parra JC, Arbelo JM.

    Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation.

    JOURNAL OF PARKINSONS DISEASE . 9(1): 173-182. Nº de citas: 8

    [doi:10.3233/JPD-181324]

  • Pastor Ó, Guzmán-Lafuente P, Serna J, Muñoz-Hernández M, López Neyra A, García-Rozas P, García-Seisdedos D, Alcázar A, Lasunción MA, Busto R, Lamas Ferreiro A.

    A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics.

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY . 63: 197-205. Nº de citas: 7

    [doi:10.1016/j.jnutbio.2018.09.026]

  • Muñoz MD, Solís JM.

    Characterisation of the mechanisms underlying the special sensitivity of the CA2 hippocampal area to adenosine receptor antagonists.

    Neuropharmacology . 144: 9-18. Nº de citas: 7

    [doi:10.1016/j.neuropharm.2018.10.017]

  • Martín-Palomeque G, Cabañes-Martínez L, de Blas Beorlegui G, Moreno Galera MDM, López JR, Burgos FJ, Regidor Bailly-Baillière I.

    Novel Mapping Method for the Intraoperative Neurophysiologic Monitoring of Sexual Function During Prostate Surgery.

    JOURNAL OF CLINICAL NEUROPHYSIOLOGY . 35(6): 463-467.

    [doi:10.1097/WNP.0000000000000506]

  • Anciones C, de Felipe A, de Albóniga-Chindurza A, Acebrón F, Pián H, Masjuán J, Corral I.

    Acute Stroke as First Manifestation of Cerebral Aspergillosis.

    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES . 27(11): 3289-3293. Nº de citas: 6

    [doi:10.1016/j.jstrokecerebrovasdis.2018.07.031]

  • Alonso-Canovas A, Lopez-Sendon Moreno JL, Buisan J, Sainz de la Maza S, Costa-Frossard L, Garcia-Ribas G, de Felipe-Mimbrera A, Matute-Lozano MC, Zarza Sanz B, Toledano Delgado R, Corral I, Masjuan J, Martinez-Castrillo JC.

    Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.

    JOURNAL OF NEUROLOGY . 265(10): 2363-2369. Nº de citas: 3

    [doi:10.1007/s00415-018-9006-5]

  • Zapata-Wainberg G, Ximénez-Carrillo Á, Trillo S, Fuentes B, Cruz-Culebras A, Aguirre C, Alonso de Leciñana M, Vera R, Bárcena E, Fernández-Prieto A, Méndez-Cendón JC, Caniego JL, Díez-Tejedor E, Masjuan J, Vivancos J, Madrid Stroke Network.

    Mechanical thrombectomy in orally anticoagulated patients with acute ischemic stroke.

    JOURNAL OF NEUROINTERVENTIONAL SURGERY . 10(9): 834-838. Nº de citas: 21

    [doi:10.1136/neurintsurg-2017-013504]

  • Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico A, Benavente Fernández L, Masjuan Vallejo J, Gállego Culleré J, Freijó Guerrero MD, Egido J, Gómez Sánchez JC, Martínez Domeño A, Purroy F, Vives Pastor B, Rodríguez Yáñez M, Vivancos J.

    Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    NEUROLOGIA . 33(7): 419-426. Nº de citas: 4

    [doi:10.1016/j.nrl.2016.07.005]

  • Estevez-Fraga C, Molina-Sanchez M, Alvarez-Velasco R, Agüero-Rabes P, Crespo-Araico L, Viedma-Guiard E, Cruz-Culebras A, Matute C, Vera R, De Felipe-Mimbrera A, Masjuan Vallejo J.

    Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists.

    Stroke Research And Treatment . 2018: 5613103-5613103. Nº de citas: 1

    [doi:10.1155/2018/5613103]

  • Gutiérrez J, Baraibar AM, Albiñana E, Velasco P, Solís JM, Hernández-Guijo JM.

    Methylmercury reduces synaptic transmission and neuronal excitability in rat hippocampal slices.

    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY . 470(8): 1221-1230. Nº de citas: 4

    [doi:10.1007/s00424-018-2144-x]

  • Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico Á, Masjuán Vallejo J, Cardona P, Castellanos Rodrigo M, Benavente Fernández L, García Pastor A, Egido J, Maciñeiras J, Serena J, Freijo Guerrero MDM, Moniche F, Vivancos J.

    Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry - The TAC 2 Study.

    Interventional neurology . 7(5): 284-295. Nº de citas: 5

    [doi:10.1159/000487518]

  • Viedma-Guiard E, Agüero P, Crespo-Araico L, Estévez-Fraga C, Sánchez-Díez G, López-Sendón JL, Aviles-Olmos I, García-Ribas G, Palacios Romero ML, Masjuan Vallejo J, Martínez-Castrillo JC, Alonso-Cánovas A.

    Use of e-mail for Parkinson's disease consultations: Are answers just a clic away?

    NEUROLOGIA . 33(2): 107-111. Nº de citas: 2

    [doi:10.1016/j.nrl.2016.05.020]

  • Martí-Fàbregas J, Medrano-Martorell S, Merino E, Prats-Sánchez L, Marín R, Delgado-Mederos R, Camps-Renom P, Martínez-Domeño A, Gómez-Choco M, Lara L, Casado-Naranjo I, Cánovas D, Torres MJ, Freijo M, Calleja A, Bravo Y, Cocho D, Rodríguez-Campello A, Zandio B, Fuentes B, de Felipe A, Llull L, Maestre J, Hernández M, Garcés M, De Arce-Borda AM, Palomeras E, Rodríguez-Yáñez M, Díaz-Maroto I, Serrano M, Fernández-Domínguez J, Sanahuja J, Purroy F, Zedde M, Delgado-Mengual J, Gich I.

    Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke.

    SCIENTIFIC REPORTS . 8(1): 1492-1492. Nº de citas: 7

    [doi:10.1038/s41598-018-20055-3]